Period:
Draw Mode:
| Volume | 36,151 |
|
|||||
| News | - | ||||||
| Day High | 0.1734 | Low High |
|||||
| Day Low | 0.1656 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BioLargo Inc (QB) | BLGO | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0038 | -2.19% | 0.17 | 13:18:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.1701 | 0.1656 | 0.1734 | 0.1738 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 22 | 36,151 | $ 0.16961 | $ 6,132 | - | 0.15 - 0.3005 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:18:25 | 101 | $ 0.17 | USD |
BioLargo Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 48.4M | 285.15M | 167.67M | 5.88M | -4.47M | -0.02 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BioLargo (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BLGO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.1626 | 0.1747 | 0.162 | 0.1669836 | 113,326 | 0.0074 | 4.55% |
| 1 Month | 0.1729 | 0.1849 | 0.1611 | 0.1718001 | 165,573 | -0.0029 | -1.68% |
| 3 Months | 0.189 | 0.1943 | 0.15 | 0.1728849 | 263,750 | -0.019 | -10.05% |
| 6 Months | 0.2049 | 0.2074 | 0.15 | 0.1820998 | 266,819 | -0.0349 | -17.03% |
| 1 Year | 0.28 | 0.3005 | 0.15 | 0.1987962 | 270,439 | -0.11 | -39.29% |
| 3 Years | 0.148 | 0.35 | 0.10 | 0.2004191 | 357,396 | 0.022 | 14.86% |
| 5 Years | 0.289 | 0.395 | 0.10 | 0.2034321 | 308,737 | -0.119 | -41.18% |
BioLargo (QB) Description
| BioLargo, Inc. invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over thirteen years of extensive R&D, BLGO holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BLGO has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets. |